Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis
Richa Mishra, Sakshi Kohli, Nitish Malhotra, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 518
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

Biology of antimicrobial resistance and approaches to combat it
Sarah Schrader, Julien Vaubourgeix, Carl Nathan
Science Translational Medicine (2020) Vol. 12, Iss. 549
Open Access | Times Cited: 144
Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis
Sander N. Goossens, Samantha L. Sampson, Annelies Van Rie
Clinical Microbiology Reviews (2020) Vol. 34, Iss. 1
Open Access | Times Cited: 122
Effects of Hydrogen Sulfide on the Microbiome: From Toxicity to Therapy
André G. Buret, Thibault Allain, Jean‐Paul Motta, et al.
Antioxidants and Redox Signaling (2021) Vol. 36, Iss. 4-6, pp. 211-219
Open Access | Times Cited: 98
Moxifloxacin-Mediated Killing of Mycobacterium tuberculosis Involves Respiratory Downshift, Reductive Stress, and Accumulation of Reactive Oxygen Species
Somnath Shee, Samsher Singh, Ashutosh Tripathi, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 9
Open Access | Times Cited: 40
Machine Learning of All Mycobacterium tuberculosis H37Rv RNA-seq Data Reveals a Structured Interplay between Metabolism, Stress Response, and Infection
Reo Yoo, Kevin Rychel, Saugat Poudel, et al.
mSphere (2022) Vol. 7, Iss. 2
Open Access | Times Cited: 39
Mechanopathology of biofilm-like Mycobacterium tuberculosis cords
Richa Mishra, Mélanie T. M. Hannebelle, Vishal P. Patil, et al.
Cell (2023) Vol. 186, Iss. 23, pp. 5135-5150.e28
Open Access | Times Cited: 26
Potential Repurposed Drug Candidates for Tuberculosis Treatment: Progress and Update of Drugs Identified in Over a Decade
Khushbu Sharma, Faraz Ahmed, Tarina Sharma, et al.
ACS Omega (2023) Vol. 8, Iss. 20, pp. 17362-17380
Open Access | Times Cited: 25
Actionable mechanisms of drug tolerance and resistance in Mycobacterium tuberculosis
Dipanwita Datta, Shaina Jamwal, Nishant Jyoti, et al.
FEBS Journal (2024) Vol. 291, Iss. 20, pp. 4433-4452
Open Access | Times Cited: 12
TcrXY is an acid-sensing two-component transcriptional regulator of Mycobacterium tuberculosis required for persistent infection
Miljan Stupar, Lendl Tan, Edward D. Kerr, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Host stress drives tolerance and persistence: The bane of anti-microbial therapeutics
Sophie Hélaine, Brian P. Conlon, Kimberly M. Davis, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 6, pp. 852-862
Open Access | Times Cited: 10
Posttranslational modification of a histone-like protein regulates phenotypic resistance to isoniazid in mycobacteria
Alexandra Sakatos, Gregory H. Babunovic, Michael R. Chase, et al.
Science Advances (2018) Vol. 4, Iss. 5
Open Access | Times Cited: 68
Growth ofMycobacterium tuberculosisat acidic pH depends on lipid assimilation and is accompanied by reduced GAPDH activity
Alexandre Gouzy, Claire Healy, Katherine A. Black, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 32
Open Access | Times Cited: 50
Rifamycin antibiotics and the mechanisms of their failure
Rebekah A. Adams, Gabrielle Leon, Natalia M. Miller, et al.
The Journal of Antibiotics (2021) Vol. 74, Iss. 11, pp. 786-798
Closed Access | Times Cited: 47
CinA mediates multidrug tolerance in Mycobacterium tuberculosis
Kaj M. Kreutzfeldt, Robert S. Jansen, Travis Hartman, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 36
Types and functions of heterogeneity in mycobacteria
Eun Seon Chung, William Johnson, Bree B. Aldridge
Nature Reviews Microbiology (2022) Vol. 20, Iss. 9, pp. 529-541
Open Access | Times Cited: 35
Mesenchymal stem cells offer a drug-tolerant and immune-privileged niche to Mycobacterium tuberculosis
Neharika Jain, Haroon Kalam, Lakshyaveer Singh, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 49
Tolerance and Persistence to Drugs: A Main Challenge in the Fight Against Mycobacterium tuberculosis
Francesca Boldrin, Roberta Provvedi, Laura Cioetto Mazzabò, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 45
In Vivo Imaging with Genetically Encoded Redox Biosensors
Alexander I. Kostyuk, Anastasiya S. Panova, Aleksandra D. Kokova, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8164-8164
Open Access | Times Cited: 42
Repurposed drug candidates for antituberculosis therapy
Qi An, Chungen Li, Yao Chen, et al.
European Journal of Medicinal Chemistry (2020) Vol. 192, pp. 112175-112175
Closed Access | Times Cited: 40
Morphological profiling of tubercle bacilli identifies drug pathways of action
Trever C. Smith, Krista M. Pullen, Michaela C. Olson, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 31, pp. 18744-18753
Open Access | Times Cited: 39
Host-acting antibacterial compounds combat cytosolic bacteria
Xiaoye Liu, Yifan Wu, Changsi Mao, et al.
Trends in Microbiology (2022) Vol. 30, Iss. 8, pp. 761-777
Closed Access | Times Cited: 23
Chemical genetic interactions elucidate pathways controlling tuberculosis antibiotic efficacy during infection
Peter O. Oluoch, Eun‐Ik Koh, Megan K. Proulx, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 9
Open Access
Unraveling Mycobacterium tuberculosis acid resistance and pH homeostasis mechanisms
Janïs Laudouze, Stéphane Canaan, Alexandre Gouzy, et al.
FEBS Letters (2025)
Open Access
Multiomic analysis identifies suppressive myeloid cell populations in human TB granulomas.
Neharika Jain, Emmanuel C. Ogbonna, Zoltan Maliga, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Oxidative damage and delayed replication allow viable Mycobacterium tuberculosis to go undetected
Kohta Saito, Saurabh Mishra, Thulasi Warrier, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 621
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top